Youngy Health Co., Ltd.
Symbol: 300247.SZ
SHZ
2.97
CNYMarktpreis heute
68.1562
P/E-Verhältnis
4.6551
PEG-Verhältnis
2.39B
MRK Kapital
- 0.00%
DIV Rendite
Youngy Health Co., Ltd. (300247-SZ) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 493.1 | 409.3 | 235.6 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 374 | 341 | 144.3 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 51.8 | 54.3 | 65.6 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 143.9 | 186.6 | 149.2 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 129.2 | 116.5 | 51 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 818 | 766.7 | 501.4 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 224.9 | 246.1 | 259.4 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 42.8 | 44.9 | 55.5 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | -323 | -290.1 | -10.9 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 7 | 3.1 | 1.9 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 451.9 | 416.1 | 214.7 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 403.5 | 420.1 | 520.7 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 47.4 | 52.7 | 52 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 12 | 10.4 | 7 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 2.7 | 3.6 | 2.7 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | -19.1 | -15.9 | 0.1 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 1.7 | 2.4 | 1.9 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 24.5 | 32.9 | 33.2 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5.4 | 17 | 25.1 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 148.9 | 158 | 161.1 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 804 | 804 | 804 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -1200.1 | -1226.7 | -1353 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 45.1 | 66.5 | 35.3 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1367.7 | 1345.1 | 1345.1 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1016.8 | 989 | 831.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1221.6 | 1186.8 | 1022.2 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 55.9 | 39.8 | 29.7 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 1072.7 | 1028.8 | 861.1 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 50.9 | 50.9 | 133.4 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 17.3 | 27.4 | 32.1 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | -101.8 | -40.9 | -59.2 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 133.3 | 31.4 | -55.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 28.4 | 22.6 | 18.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -6.7 | -1.9 | -1.1 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -51.9 | -18.9 | 75.4 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | -14.7 | 15.9 | 24.1 | |||||||||||||||||
cash-flows.row.inventory | 0 | -40 | -44 | 3.2 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -3.9 | 7.4 | 47 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 6.7 | 1.9 | 1.1 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -139.1 | -24.3 | 42.3 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1.2 | 0.2 | 35.5 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -800.7 | -374.7 | -355.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 805.5 | 256.5 | 368.4 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 19.1 | 55 | 0.5 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 7.6 | -69.3 | 39.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -11.6 | -5.7 | -25 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.9 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -11.6 | -5.7 | -10.8 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -11.6 | -5.7 | -36.7 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 10.1 | -4.5 | -10.1 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -23 | -68.7 | 73.9 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 68.3 | 91.3 | 160 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 91.3 | 160 | 86.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -29.2 | 10.8 | 81 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -17.5 | -6.2 | -8.7 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | -46.7 | 4.6 | 72.3 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 529.4 | 463.3 | 526.5 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 355.5 | 352 | 399.3 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 174 | 111.3 | 127.2 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 132.2 | 119.2 | 112.2 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 487.6 | 471.2 | 511.5 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 7.9 | 2.9 | 2.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 13.7 | 4 | 15.3 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 0.3 | -0.8 | -0.5 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0.6 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 28 | 28.4 | 22.6 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 59.4 | 137.2 | 38.3 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 59.8 | 136.4 | 37.8 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 17.8 | 3.1 | 6.3 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 26.6 | 126.3 | 24.2 |
Häufig gestellte Frage
Wie hoch ist die Youngy Health Co., Ltd. (300247.SZ) Gesamtvermögen?
Youngy Health Co., Ltd. (300247.SZ) Gesamtvermögen ist 1221559067.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.332.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 0.115.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.066.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.130.
Was ist der Youngy Health Co., Ltd. (300247.SZ) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 26582643.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 17332369.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 132173058.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.